echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Using these drugs to treat Alzheimer's disease reduces the mortality rate by 27%

    Using these drugs to treat Alzheimer's disease reduces the mortality rate by 27%

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Alzheimer's disease is a cognitive brain disease that affects millions of patients worldwide.


    Cholinesterase inhibitors are drugs recommended for the treatment of Alzheimer's disease.


    For up to five years after the diagnosis, the use of these drugs has consistently benefited from the cognitive aspect, and the mortality rate has also been reduced.


    Hong Xu et al, Long Term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality, Neurology (2021).


    Hong Xu et al, Long Term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality, Neurology (2021).


    There are three drugs (cholinesterase inhibitors) used to treat Alzheimer's disease: galantamine, donepezil, and rivastigmine.


    However, the effects of these drugs have been controversial, partly because of relatively few longitudinal studies.


    The results showed that, compared with the control group, treatment with cholinesterase inhibitors was associated with a slower decline in cognitive abilities within 5 years, and a 27% reduction in patient mortality.


    Compared with the control group, treatment with cholinesterase inhibitors was associated with a slower decline in cognitive abilities within 5 years and a 27% reduction in patient mortality.


    "This result provides strong support for recommending the use of cholinesterase inhibitors for the treatment of patients with Alzheimer's disease, and also shows that treatment will last a long time.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.